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Abstract
Background: The reduction of crime is an important outcome of opioid maintenance treatment (OMT). Criminal
intensity and treatment regimes vary among OMT patients, but this is rarely adjusted for in statistical analyses,
which tend to focus on cohort incidence rates and rate ratios. The purpose of this work was to estimate the
relationship between treatment and criminal convictions among OMT patients, adjusting for individual covariate
information and timing of events, fitting time-to-event regression models of increasing complexity.
Methods: National criminal records were cross linked with treatment data on 3221 patients starting OMT in Norway
1997–2003. In addition to calculating cohort incidence rates, criminal convictions was modelled as a recurrent event
dependent variable, and treatment a time-dependent covariate, in Cox proportional hazards, Aalen’s additive hazards,
and semi-parametric additive hazards regression models. Both fixed and dynamic covariates were included.
Results: During OMT, the number of days with criminal convictions for the cohort as a whole was 61% lower than
when not in treatment. OMT was associated with reduced number of days with criminal convictions in all time-to-
event regression models, but the hazard ratio (95% CI) was strongly attenuated when adjusting for covariates; from
0.40 (0.35, 0.45) in a univariate model to 0.79 (0.72, 0.87) in a fully adjusted model. The hazard was lower for females
and decreasing with older age, while increasing with high numbers of criminal convictions prior to application to OMT
(all p < 0.001). The strongest predictors were level of criminal activity prior to entering into OMT, and having a recent
criminal conviction (both p < 0.001). The effect of several predictors was significantly time-varying with their effects
diminishing over time.
Conclusions: Analyzing complex observational data regarding to fixed factors only overlooks important temporal
information, and naïve cohort level incidence rates might result in biased estimates of the effect of interventions.
Applying time-to-event regression models, properly adjusting for individual covariate information and timing of various
events, allows for more precise and reliable effect estimates, as well as painting a more nuanced picture that can aid
health care professionals and policy makers.
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Background
Experimental setups and randomized controlled trials
have been invaluable to the medical research revolution
over the past decades. However, not all diseases and in-
terventions lend themselves to stylized setups, and com-
plex observational data is often the only available source
of information. An analytical challenge is the often large
heterogeneity between individuals in treatment regimes
and the timing of various events. HIV patients drift in
and out of treatment [1,2], cancer patients may, or may
not, have multiple relapses [3,4] and drug users will
change their drug preferences, be enrolled in various
treatments, drop out, overdose or die, at varying stages
during the course of treatment [5-8]. Nevertheless, ac-
curate and reliable estimates of the effect of often costly
interventions are still essential, both for health care pro-
fessionals and policy makers.
Heroin users as a group have been found to engage in
high levels of criminal activity [9-12], and the reduction
of crime is an important aspect of maintenance treat-
ment [13]. Several observational studies have found that
opioid maintenance treatment (OMT) reduces the level
of criminal activity among heroin users [5,14,15]. Esti-
mating of the effect of OMT is however complicated, as
OMT patients differ greatly in characteristics and dur-
ation of engagement with treatment. Studies have found
that patients cycle in and out of treatment, often for
multiple episodes [16]. Retention in treatment has con-
sistently been found to be associated with crime out-
come [13,17], and longer continuous periods in OMT
has been associated with improved outcomes [17].
Individual covariate information and timing of events
is however rarely taken into account in OMT research,
or when studying criminal activity in heroin users. Focus
has been on simple cohort counts and incidence rates,
and criminal events grouped based on retrospectively
defined criteria conditioned on the termination date of
the study [12,18]. This is problematic for several reasons.
Firstly, this approach only studies outcomes at a mean
group level, not taking intra-individual behavior into ac-
count, both with relation to criminal activity and treat-
ment history. Further, without individual based regression
models, confounders cannot be properly adjusted for, or
associations tested for statistical significance. Finally, not
adjusting for censoring introduces bias of unknown direc-
tion and magnitude.
Time-to-event analysis, traditionally referred to as sur-
vival analysis, is a cornerstone of modern medical statis-
tical analysis, including the seminal work by Cox [19,20].
Over the past decades the field of time-to-event analysis
has developed rapidly, and increasingly more complex
situations can now be analyzed within the statistical
framework of counting processes [21,22]. Approaching
the analysis of criminal activity in OMT patients as a set
of individual counting processes allows for modeling of
individual time courses, with criminal activity as a recurrent
event outcome, treatment as a time-dependent covariate,
and adjustment for possible confounding variables, both
fixed, dynamic, and with time-varying effects.
The purpose of this work was to estimate the relation-
ship between OMT and criminal convictions among her-
oin users on OMT when adjusting for individual covariate
information and timing of events, fitting time-to-event re-
gression models of increasing complexity. We fit univari-
ate and multiple Cox proportional hazards, Aalen’s
additive hazards and semi-parametric additive hazards re-
gression models, exploring whether increased model com-
plexity paint a more nuanced picture of the situation than
has previously been reported. We find that simple analyses
might overestimate the effect of treatment, while includ-
ing too much detail on the overall process might result in
corresponding underestimation.
Methods
Data material
Complete records on all 3221 patients who started OMT
in Norway from September 1997 through December 2003
were cross linked with official national criminal records
from the Norwegian crime statistics (Statistics Norway)
December 2007, with information including date of crime
and offence details. The last study day was 31 December
2003, thus being the censoring time for all patients, be-
sides the 135 patients who died before this, who were cen-
sored at their time of death. The data has been analyzed
previously, and a full description on the study settings and
participants can be found elsewhere [8,12,18].
The Norwegian crime statistics from 1995 to 2003
provide data on date of all crimes registered by the po-
lice in the period, penal code and various prosecution
decisions. All convictions are decisions finding a person
guilty of a crime in the court of law. In our study, only
formal final convictions were included in the analysis.
Similarly, convictions on use and possession of illegal
drugs were excluded from the analysis, as these data
would potentially be particularly influenced by the seve-
rity of their drug dependence. We focus here on ‘crime
days’; any day with one or more criminal convictions
was considered a ‘crime day’.
The patients had from one to six treatment episodes of
various lengths. Due to relatively few long observation
times, the various time-to-event models were fitted only up
until 6 years from application to the OMT programme.
Ethics
The study was approved by the Regional Committees
for Medical and Health Research Ethics, The Norwegian
Social Science Data Services (NSD) and the Norwegian
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Directorate of Health and the Police Directorate. Files
were merged and made anonymous by Statistics Norway.
Statistical methodology
A crude estimate of treatment effect was calculated as
the total number of days with criminal convictions in
and outside of OMT, divided by the corresponding total
number of risk days, that is, the incidence rate. Corre-
sponding confidence intervals were calculated using the
non-parametric bootstrap [23].
Following a recent publication on temporal changes in
criminal convictions in OMT patients [24] we also calcu-
lated the day-by-day mean number of days with criminal
convictions in and outside of OMT separately in the follow-
ing manner. Suppose that m individuals are observed over
time. Let mst denote the total number of individuals with
treatment status s at time t and Ni(t) the number of events
at time t for the ith process. Then the sample mean at time
t for treatment status s under study is μ^s tð Þ ¼ 1mst
X
mst
Ni tð Þ.
A cubic smoothing spline was fitted to this temporal sam-
ple mean to ease the interpretation.
We then fitted various time-to-event regression models
with increasing model complexity as described below.
Counting processes
The flexible mathematical framework of counting pro-
cesses is specifically designed for handling time-to-event
data on an individual level [21,22]. It encompasses statis-
tical techniques like the Kaplan-Meier plot and the log-
rank test, as well as Cox proportional hazards and Aalen’s
additive hazards multiple regression models, which allow
for the adjustment of various types of covariates. In the
present study the outcome variable, day with a criminal
activity leading to conviction, is a recurrent event. Further,
as treatment is not fixed at baseline, but varies over time,
it was included as a time-dependent covariate.
Fixed covariates
Gender and age at time of application to OMT were
added in the regression models as fixed covariates, along
with variables describing criminal activity prior to appli-
cation and criminal activity while on waiting list for
OMT. The latter two variables are described below.
Data on criminal convictions from three years prior to
application to treatment was included in the material as
covariate information, categorized into three categories;
patients with no convictions during the pre-treatment
period (n = 769), 1–27 convictions (n = 2097), and more
than 27 convictions (n = 355).
A natural candidate estimator for the criminal inten-
sity while on waiting list for OMT is the number of days
with criminal convictions divided by total number of
days while on waiting list. However, as some individuals
in the cohort spent zero days on waiting this variable
was undefined for these individuals. The variable was
also strongly zero-inflated as the majority of individuals
had zero crime days while on waiting list. We thus in-
cluded the dichotomous variable ‘criminal conviction
while on waiting list: yes/no’ as a marker for criminal ac-
tivity while on waiting list for OMT.
Dynamic covariates
In order to incorporate the dynamic nature of the problem
under study in the analysis, we added two time-dynamic
covariates. A dynamic covariate is a type of internal
covariate, intermediate between the fixed covariate
and the outcome, and may “steal” some of the effect
from the fixed covariate, e.g. treatment [22,25]. Using
dynamic covariates together with fixed covariates thus
requires some caution.
A possibility when modeling the dynamic nature of re-
current events, e.g. criminal convictions, is to include
dynamic covariates of the kind ‘time since previous
event’ [22]. In our study, however, several individuals
had no criminal convictions throughout the observa-
tional period, leaving such a variable undefined for sev-
eral individuals in the cohort. Alternatively, counting the
number of events within a recent time window, e.g. last
30 days, also captures some of the dynamics. This vari-
able was well-defined in our data, but was strongly zero-
inflated. We thus included the dichotomous variable
‘one or more days with criminal conviction last 30 days:
yes/no’ as a dynamic variable in the analyses.
Multiple treatment episodes, as compared to reten-
tion in treatment, has been found to be associated with
increased criminal activity, and we thus wanted to in-
clude the accumulated number of treatments as a dy-
namic variable in the regression models. However,
while individuals had from one through six treatments,
relatively few individuals had more than two treat-
ments, and including this as a categorical variable with
six ordinal levels led to a breakdown in the model fit-
ting procedures. We thus added as a dynamic variable a
dichotomous marker of whether the accumulated num-
ber of treatments was more than one.
Cox proportional hazards model
We fitted univariate, multiple and dynamic Cox propor-
tional hazards regression models [19,20]. The appropri-
ateness of the Cox model was assessed by plotting scaled
Schöenfeld residuals and an accompanying test for zero
slope therein [26]. While examining this model diagnos-
tic reveals whether the proportional hazards assumption
is met or not, such residual plots will not so easily give
information on the nature of non-proportionalities.
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Aalen’s additive hazards model
A typical deviation from the Cox model is that the effect
of covariates change with time; a treatment might have
one effect initially, which is later weakened. Two well-
known reasons for such diminishing effects are aging
measurements and frailty [22]. Aging means that baseline
variables become less representative over time, and their
effect thus smaller. The concept of frailty, on the other
hand, is that, as time goes by, the individuals left in the
study are less “frail”, e.g. died or dropped out. Hence,
when comparing treatments, the remaining individuals in
both groups will be less and less likely to experience an
event the higher the initial risk, and the treatment effect
will decrease with time. Frailty models aim to account for
such unobserved heterogeneity between groups.
Whether a treatment effect is time-varying or constant
with time might often itself be the main research ques-
tion in an analysis. An alternative to the Cox model,
which does not condition on constant proportional haz-
ard over time, is Aalen’s additive hazards model [27].
Here covariate effects are allowed to vary freely over
time. Rather than the hazard rate, the target for such an
analysis is cumulative regression functions. These are
plotted against time to give a description of how the co-
variates influence the outcome over time, and it is the
change in the cumulative functions, i.e. the slope, that is
of primary interest. Dynamic analysis of recurrent event
data using the additive hazards model has been sug-
gested in the statistical literature previously [28].
Semi-parametric additive hazards model
A useful sub-class of the additive hazards model is the
semi-parametric additive hazards model [29]. Here the ef-
fect of some covariates is allowed to vary with time, while
the effect of other covariates is assumed to be constant.
Calculations
The statistical analysis was performed in R 2.12 [30]. The
Cox proportional hazards regression models were fitted
using package coxph, based on the counting process for-
mulation of Andersen and Gill [19]. Aalen’s additive haz-
ards and semi-parametric additive hazards regression
models were fitted using package timereg, based on the
work of Martinussen and Scheike [31]. The effect of the
recurrent criminal events and time-dependent treatment
covariate on an individual level was controlled for using
robust estimation [32]. P-values below 0.05 were consid-
ered statistically significant.
Results
Incidences
The number of crime days per 1000 days for when in
OMT and not was 1.16 and 3.87, respectively, giving an
incidence ratio (95% CI) of 0.39 (0.36, 0.41). That is, for
the cohort as a whole there is approximately 60% fewer
days with criminal convictions when in treatment. Per-
forming subgroup analysis of incidence ratios for men
and women separately, we find similar incidence ratios
for both groups, with 0.39 (0.36, 0.41) for men and 0.41
(0.36, 0.46) for women. That is, the relationship between
treatment and criminal convictions appears to be similar
for both genders. Women are generally considerably less
criminally active than men, and performing subgroup
analysis for in and out of treatment separately, we find
incidence rate ratios of criminal convictions for women
as compared to men to be 0.50 (0.45, 0.56) for when in
treatment and 0.48 (0.43, 0.53) otherwise. That is, men
generally have twice as many days with criminal convic-
tions as do women, whether in treatment or not.
The day-by-day number of days with criminal convic-
tions per individuals at risk throughout the observational
period appears to be markedly lower when the individuals
in the cohort are in treatment as compared to when they
are not (Figure 1). The cumulative incidence for 16 ran-
dom individuals demonstrates large individual differences
not accounted for in the crude analyses above (Figure 2).
Cox proportional hazards model
Results from Cox proportional hazard regression models
with crime days as a recurrent event and treatment as a
time-dependent explanatory variable is shown in Table 1.
We fitted univariate models for all eight covariates and
three multiple models with increasing number of covari-
ates. In univariate analysis, being in treatment more than
halves the hazard for criminal convictions, HR (95% CI)
0.40 (0.35, 0.45). Older age and being female also reduces
the hazard for criminal convictions, while many criminal
convictions prior to application, criminal convictions
while on waiting list, more than one OMT-episode, and
criminal convictions past 30 days all increase the hazard
for criminal convictions. All univariate estimates are how-
ever attenuated when adjusting for other covariates in
multiple regression models. In the full model with all eight
covariates, fixed and dynamic, being in treatment is es-
timated to reduce hazard for criminal convictions by
approximately one fifth, HR (95% CI) 0.79 (0.72, 0.87).
This is substantially less than in the unadjusted ana-
lysis. Results from Cox proportional hazards regression
models should however be interpreted with care, as the
models fail the test for the assumption of proportional
hazards (not shown).
Aalen’s additive hazards model
Results from Aalen’s additive hazards regression models
with crime days as a recurrent event and treatment as a
time-dependent explanatory variable is shown in Figure 3.
We fitted univariate models for all eight covariates and
a multiple model with all covariates. Accompanying
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statistical tests show that all variables are highly statisti-
cally significant in all models (all p < 0.001). The effects
of treatment, criminal convictions while on waiting list
and criminal conviction past 30 days are significantly
time-varying (all p < 0.05). All univariate estimates are
attenuated when adjusting for other covariates in mul-
tiple regression models (Figure 3).
Semi-parametric additive hazards model
Results from Aalen’s additive hazards regression model
indicate that the effect of age, gender criminal activity
prior to OMT and accumulated number of treatments can
be assumed to be constant over time. Results from the
corresponding semi-parametric additive hazards regres-
sion model are shown in Table 2 and Figure 3. All vari-
ables are strongly statistically significant (all p < 0.005).
The evidence of time-varying effects of treatment, crim-
inal convictions while on waiting list and criminal convic-
tion past 30 days is strengthened (all p < 0.025).
Discussion
In the present study we have fitted various time-to-event
regression models in order to explore the relationship
between opioid maintenance treatment (OMT) and
criminal convictions in heroin users. Previous analyses
have focused on simple incidence rates and subgroup
analyses [18]. We refine these results by replacing simple
cohort averages with estimates from regression models
in prospective time, adjusting for individual covariate in-
formation and timing of events. While these effect esti-
mates not necessarily represent causal effects, they are a
marked improvement over mere counts. Notably, even
the simplest of these time-to-event models might be
considered relatively complex in the larger body of the
research literature in the field, being the first study of
OMT data to include both a recurrent event outcome
and a time-dependent treatment variable.
Simple, unadjusted analyses are a natural first step in
any data analysis. However, it must still be a first step in
the right direction. When analyzing timed events, unless
every individual under study has been allowed sufficiently
time to experience the event(s) or not, time-to-event data
will be censored at a time selected by the analyst. Not ac-
counting for this censoring will result in a bias of un-
known direction and magnitude. While the mathematical
framework of counting processes automatically adjust for
this, other, simpler, approaches do not. Defining categories
like in-treatment, between-treatments and after treatment,
when people can have an unknown number of treatments
and be eligible for more treatments for an unknown
amount of time, implies using information from the fu-
ture; whether a non-treatment period is “in-between” or
“after” treatment(s) depends on the end-date of the study,
i.e. the censoring date. Applying time-to-event regression
models helps to improve the quality of the information ex-
tracted from data like this.
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Figure 1 Day-by-day mean number of criminal convictions. Day-by-day number of criminal convictions (crime days) per people at risk (grey
dots), with cubic smoothing spline superimposed (black lines), for a cohort of 3221 Norwegian heroin users when in opioid maintenance treatment
(OMT) and not.
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In the OMT data under study, the naïve incidence rate
ratio estimate indicate about 60% fewer criminal convic-
tions while in treatment as compared to not in treat-
ment, for both men and women. The individual based
unadjusted Cox model also shows strong effect of treat-
ment, with being in treatment reducing HR for criminal
convictions by more than 50%. However, this result is
strongly attenuated in the full model, adjusting for fixed
demographic covariates and dynamic covariates. Indeed,
in the full model the estimated reduction in HR for crim-
inal conviction when in treatment is reduced to about one
third, to approximately 20%. Crude, unadjusted estimates
of the effect of OMT should consequently be interpreted
with care.
It is worth noting that the reduction of the estimated
effect of treatment is not mainly due to adjusting for
traditional covariates such as age and gender, but when
adjusting for covariates related to the particular problem
under study, such as baseline crime, current crime and
accumulated number of treatment periods. The two lat-
ter are dynamic covariates, and such internal covariates
are known to “steal” some of the effect of the fixed co-
variates, e.g. treatment [22]. If the research goal is the
overall effect of treatment, adjusting for previous
Figure 2 Individual cumulative incidence of criminal convictions. Cumulative incidence of criminal convictions (crime days) for 16 random
individuals in opioid maintenance treatment (OMT) from application to OMT (left dotted line) to study end December 31st 2003 (right dotted
line). Periods not in treatment (light grey area) and in treatment (dark grey area).
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criminal activity can be misleading, as the result is an
estimate of the direct effect of treatment, not the total
effect. If however the effect of the covariate, such as
previous criminal activity, is of potential interest per
se, such adjustment is causally interesting; adding co-
variates adds to the understanding of the processes and
mechanics of the situation under study. That is, what
covariates to adjust for or not depends on the research
question, and more complex models should be handled
with care.
Note that the outcome measure in the present ana-
lysis, day with criminal conviction, is not merely an
event, but an activity, setting the analysis apart from the
analysis of, say, relapse of tumors. When analyzing
things we do, that is, events that are partly, or fully, a
personal choice, rather than something that merely hap-
pens to us, the inclusion of covariates should be given
extra thought.
The Cox model is a widely used time-to-event model
in medical research. However, while many real survival
data meet the assumption of proportional hazards, this
assumption does not generally hold. It is well-known in
the statistical literature that a common feature in time-
to-event studies is that covariates “age”, i.e. their effect
weakens over time [22]. A treatment might have an ef-
fect initially, but the effect wears off as time passes, or it
takes some time before an intervention has effect. Such
time-varying effects are not naturally easily discovered in
the Cox model, but there are workarounds [22]. The
Cox model is also known to have problems with some
dynamic covariates [22]. While stratifying is a common
way of resolving such issues with the Cox model, there
are problems with this approach in the data under study.
Firstly, stratifying on a variable makes it impossible to
estimate the effect of that variable. As a primary aim in
this methodological study was to explore the relationship
between treatment and criminal convictions, stratifying on
treatment groups was not a preferable alternative. Sec-
ondly, with repeated events there might be time-varying
effects other than those caused by differences between
strata; even within strata there might be time-varying co-
variate effects. In this study related for instance to the fact
that treatment can start, and stop, at different times, and
for a different number of times for each individual.
Aalen’s additive model easily handles dynamic covari-
ates and covariates with time-varying effects [28], with
the latter being immediately apparent in the accompany-
ing plots. Interpreting results is somewhat less straight-
forward, as it is the gradients in plots of cumulative
regression functions that are central, not straightforward
tabulated, fixed numbers. Thus, in the absence of time-
varying effects, a simpler approach might be preferred.
The semi-parametric additive hazards model allows for a
mixture, with the effect of some covariates being allowed
to vary with time, while the effect of others is assumed
to be constant. In our data such a model appears to be the
best of both worlds, correctly accounting for the time-
varying effects, while strengthening the results from the
constant terms. Note that multiple-state-models [33,34]
might also be a fruitful alternative for this type of data,
along with recent developments within the field of causal
inference [35,36].
Estimation of causal effects from observational data has
been given a lot of attention in recent years. In his 2010
Armitage lecture Aalen focuses on the value of integrating
longitudinal data and survival analysis when trying to
understand treatment effects [37], and has also discussed
a dynamic viewpoint to causality, mediation and time [38].
The traditional way of unraveling direct and indirect ef-
fects, by comparing exposure effects in regression models
with and without the mediator, will often produce flawed
results, among others due to confounding from time-
dependent covariates [39]. More sophisticated methods
are thus needed. A counterfactual approach to within-
individual causal effects has been taken in an analysis of
whether marriage reduces crime [40], studying 500
high-risk boys, incorporating extensive time-varying
covariates. The fact that substance related questions,
such as the issue of a causal relationship between il-
legal drug use and selling and violent behavior, still
Table 1 Cox proportional hazards regression models
Univariate regression models Multiple regression model 1
Variable Hazard ratio (95% CI) p-value Hazard ratio (95% CI) p-value
OMT 0.40 (0.35,0.45) <0.001 0.79 (0.72,0.87) <0.001
Female gender 0.48 (0.40,0.57) <0.001 0.75 (0.66,0.85) 0.001
Age [10 years] 0.60 (0.54,0.67) <0.001 0.79 (0.73,0.85) <0.001
>27 criminal days prior to OMT application 4.83 (4.19,5.55) <0.001 1.50 (1.35,1.66) <0.001
Criminal conviction while on waiting list 6.65 (5.70,7.76) <0.001 2.84 (2.47,3.25) <0.001
>1 OMT period 1.74 (1.33, 2.28) <0.001 1.43 (1.20,1.70) <0.001
Criminal conviction last 30 days 93.9 (87.1, 101.2) <0.001 45.2 (40.4, 50.5) <0.001
Cox proportional hazards regression models with day of criminal conviction as a recurrent event outcome and opoid maintenance treatment (OMT) a
time-dependent explanatory variable. Results should be interpreted with care as the multiple model failed the assumption of proportional hazards.
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Figure 3 Additive hazards regression models. Univariate and multiple Aalen’s additive hazards regression models for days with criminal
convictions as a recurrent event dependent variable and treatment as a time-dependent covariate, and the non-parametric components of a
multiple semi-parametric additive hazards regression model.
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remains unresolved, despite a vast number of empirical
studies, has been attributed to methodological weak-
nesses that prevent causal inference [41]. However,
whether a causal model approach can indeed be taken
in addiction and crime research is unclear, as both
basic and applied research on the relationships among
drug use and crime readily illustrates threats to the val-
idity of causal inference, as even the issue of temporal
order remains unanswered: Which comes first, drug
use or crime? [42].
In our data including variables on the dynamics of the
situation under study helped uncover other important
variables than treatment. While refining the estimate of
the relationship between treatment and criminal convic-
tions was the main aim of the study, the analysis showed
that the strongest predictor by far was criminal convic-
tions past 30 days. That is, while criminal activity is rela-
tively uniformly distributed for the cohort as a whole, as
indicated by the rate ratio estimates, with a reduced level
while in treatment, on an individual level criminal convic-
tions are clustered. One should consequently be particu-
larly aware of individuals who have recently committed a
criminal offence, as these individuals are in the high risk
group of committing a new offence – irrespectively of
whether they are currently in treatment or not. Clinically
many of these individuals might be considered as having
an antisocial personality, hence a specific trait that charac-
terizes them both inside and outside of treatment.
The introduction of the simple idea of counting events
in treatment and non-treatment groups has been invalu-
able for the advancement of medical research. However,
it is not merely whether an event occurs that holds infor-
mation, but often as much when it occurs. Including this
additional attribute in the analysis will however often
dramatically increase the analytical complexity. Reliable
estimates of treatment effects are however still crucial in
order to paint a truthful picture of the various associa-
tions in the data set under study. Statistical methods for
analyzing complex time-to-event data are well-known in
the statistical literature, and the flexible framework of
counting processes can model situations far more com-
plex than what is common in the medical research litera-
ture. Such models are still relatively rare in the medical
research literature, despite the necessary computer code
being freely available.
Conclusions
For time-to-event data, be it complex observational drug
treatment data as presented here, treatment of chronic
diseases or other observational data, regression models
based on the framework of counting processes can han-
dle large heterogeneity among individuals, both in expo-
sures, treatment regimes and outcomes, as well as paint
a more nuanced picture of the situation by adjusting for
fixed and dynamic covariates, and time-varying con-
founding effects, ultimately providing more precise and
reliable information that can aid health care profes-
sionals and policy makers.
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